Sanofi Forecast, price target & analysts
Sanofi Target price 2026 - Analyst rating & recommendation
Sanofi Classifications & Recommendation:
Sanofi Price Target
| Target Price | €107.10 |
| Price | €82.32 |
| Potential |
30.10%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Sanofi 2027 .
The average Sanofi target price is €107.10.
This is
30.10%
register free of charge
€124.95
51.79%
register free of charge
€95.95
16.56%
register free of charge
|
|
| A rating was issued by 29 analysts: 23 Analysts recommend Sanofi to buy, 5 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sanofi stock has an average upside potential 2027 of
30.10%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion € | 44.29 | 45.05 |
| 6.41% | 1.73% | |
| EBITDA Margin | 23.80% | 30.75% |
| 6.03% | 29.20% | |
| Net Margin | 12.55% | 21.24% |
| 3.24% | 69.18% |
25 Analysts have issued a sales forecast Sanofi 2025 . The average Sanofi sales estimate is
This results in the following potential growth metrics:
20 Analysts have issued an Sanofi EBITDA forecast 2025. The average Sanofi EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 Sanofi Analysts have issued a net profit forecast 2025. The average Sanofi net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 4.42 | 7.86 |
| 3.03% | 77.83% | |
| P/E | 10.47 | |
| EV/Sales | 2.51 |
24 Analysts have issued a Sanofi forecast for earnings per share. The average Sanofi EPS is
This results in the following potential growth metrics and future valuations:
Current Sanofi Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| INTESA SANPAOLO EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| DAY BY DAY |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| LEERINK PARTNERS |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| HSBC GLOBAL INVESTMENT RESEARCH |
Locked
➜
Locked
|
Locked | Nov 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
INTESA SANPAOLO EQUITY RESEARCH:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
DAY BY DAY:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
LEERINK PARTNERS:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
HSBC GLOBAL INVESTMENT RESEARCH:
Locked
➜
Locked
|
Nov 25 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
